Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower
Timo Lenderink1, Eric Boersma, Anselm K Gitt
1Atrium Medical Centre, Heerlen, The Netherlands.
European Heart Journal
|July 6, 2006
Summary
Early statin initiation after acute coronary syndrome (ACS) significantly reduces 7-day mortality, particularly in ST-elevation ACS (STE-ACS) patients. Further randomized trials are needed to confirm these findings for definitive treatment recommendations.
Area of Science:
- Cardiology
- Clinical Trials
- Pharmacotherapy
Background:
- Statins are crucial for secondary prevention in cardiovascular disease.
- Optimal timing for initiating statins post-acute coronary syndrome (ACS) remains unclear.
- Emerging evidence suggests early statin administration before hospital discharge.
Purpose of the Study:
- To investigate the impact of early statin initiation on mortality following ACS.
- To test the hypothesis that statins should be administered without delay after ACS.
Main Methods:
- Analysis of a large cohort of 10,484 ACS patients.
- Comparison of early statin recipients (within 24h) versus non-recipients.
- Utilized propensity score and multivariable analysis to adjust for confounding factors.
Main Results:
- Early statin therapy significantly reduced 7-day all-cause mortality (0.4% vs 2.6%).
- Adjusted Hazard Ratio for early statin use was 0.34 (95% CI 0.15-0.79).
- Significant benefit observed in ST-elevation ACS (STE-ACS) patients, though no heterogeneity found between STE-ACS and non-STE-ACS.
Conclusions:
- Very early statin therapy is associated with reduced mortality in STE-ACS patients.
- Findings suggest potential benefits of immediate statin initiation post-ACS.
- Prospective, randomized controlled trials are required to confirm these results and guide treatment recommendations.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:26Acute Coronary Syndrome V: Nursing Management
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...